ClinicalTrials.gg
Sign In
CompletedNCT06521853Updated Nov 19, 2024

Comparison Between PEEK With Autogenous Bone Graft and PEEK With Xenograft in Maxillary Sinus Augmentation

An interventional study of PEEK With Autogenous Bone Graft and PEEK With Xenograft in Maxillary Sinus, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 20 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-19.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Jun 2023, registered Apr 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
20 Years to 50 Years
Sex
All
01

Study summary

Comparison Between PEEK With Autogenous Bone Graft and PEEK With Xenograft in Maxillary Sinus Augmentation

Read the detailed description

Comparison Between PEEK With Autogenous Bone Graft and PEEK With Xenograft in Maxillary Sinus Augmentation: clinical, radiographic and histomorphometric analysis .

02

Conditions studied

  • Maxillary Sinus

Keywords

  • maxillary sinus augmentation ; bone graft
03

In context

Lead sponsor

Cairo University is the lead sponsor of 4,909 studies on the registry; 1,445 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Browse Cairo University studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • posterior edentulous ridge less than 4mm in bone height

Exclusion criteria

Exclusion Criteria:

  • insufficient oral hygiene and motivation
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
12 participants (actual)

Study arms

  • Experimental
    PEEK With Autogenous Bone Graft

    maxillary sinus elevation using PEEK device and placement of autogenous bone graft

    Other: PEEK With Autogenous Bone Graft

  • Experimental
    PEEK With Xenograft

    maxillary sinus elevation using PEEK device and placement of xenograft

    Other: PEEK With Xenograft

Interventions

  • OtherPEEK With Autogenous Bone Graft

    placement of PEEK With Autogenous Bone Graft

  • OtherPEEK With Xenograft

    placement of PEEK With xenograft

06

What researchers measure

Primary outcomes

  1. bone height

    using CBCT in mm

    Time frame: after 6 months

Secondary outcomes

  1. bone quality

    core biopsy (Histomorphometric evaluation)

    Time frame: after 6 months

07

Study locations

1 site
  • Faculty of dentistry Cairo university
    Cairo, 14444, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2023 to primary completion in Jul 2023, 1 month.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 17, 2024
First posted
Jul 26, 2024
StartActual
Jun 1, 2023
Primary completionActual
Jul 1, 2023
CompletionActual
Dec 31, 2023
Last update
Nov 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06521853
Lead sponsor
Cairo University
Responsible party
mohamed gamal hammad (principal investigator, Cairo University) — Principal investigator
First posted
Jul 26, 2024
Start date
Jun 1, 2023
Primary completion
Jul 1, 2023
Completion
Dec 31, 2023
Last update
Nov 19, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Cairo University →

Start the discussion